What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Biochemistry, Molecular biology, Okadaic acid, Ornithine decarboxylase and Carcinogenesis.
As part of his studies on Biochemistry, he frequently links adjacent subjects like Pharmacology.
Hirota Fujiki has included themes like Heterogeneous nuclear ribonucleoprotein, Protein kinase C, MAP2K7 and Virology in his Molecular biology study.
His study in Okadaic acid is interdisciplinary in nature, drawing from both Toxin and DMBA.
His Ornithine decarboxylase research is multidisciplinary, incorporating elements of In vitro, Structure–activity relationship, Enzyme inducer, Carcinogen and Marine toxin.
His biological study focuses on Tumor promotion.
His most cited work include:
- Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter (517 citations)
- Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity. (506 citations)
- Wide Distribution of 3H-epigallocatechin Gallate, a Cancer Preventive Tea Polyphenol, in Mouse Tissue (446 citations)
What are the main themes of his work throughout his whole career to date?
Hirota Fujiki focuses on Biochemistry, Molecular biology, Okadaic acid, Carcinogenesis and Internal medicine.
His study in Protein kinase C, Receptor, Ornithine decarboxylase, In vitro and Aplysiatoxin is done as part of Biochemistry.
His Molecular biology research incorporates themes from Cell, Messenger RNA, Gene expression, Gene and Tissue culture.
As a part of the same scientific family, Hirota Fujiki mostly works in the field of Carcinogenesis, focusing on Pharmacology and, on occasion, Apoptosis.
As part of the same scientific family, Hirota Fujiki usually focuses on Internal medicine, concentrating on Endocrinology and intersecting with Thapsigargin and 12-O-Tetradecanoylphorbol-13-acetate.
As a member of one scientific family, he mostly works in the field of Tumor promotion, focusing on Cancer research and, on occasion, Epigallocatechin gallate, Immunology and Tumor necrosis factor alpha.
He most often published in these fields:
- Biochemistry (46.73%)
- Molecular biology (29.91%)
- Okadaic acid (17.29%)
What were the highlights of his more recent work (between 1998-2014)?
- Cancer (9.35%)
- Internal medicine (16.82%)
- Tumor necrosis factor alpha (6.54%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer, Internal medicine, Tumor necrosis factor alpha, Carcinogenesis and Cancer research.
The various areas that Hirota Fujiki examines in his Cancer study include Lung cancer and Pharmacology.
His research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with problems in Oncogene.
His work deals with themes such as Tumor promotion and Biochemistry, which intersect with Tumor necrosis factor alpha.
His Tumor promotion study combines topics from a wide range of disciplines, such as Proinflammatory cytokine, Okadaic acid and Traditional medicine.
His studies deal with areas such as Signal transduction and DMBA as well as Okadaic acid.
Between 1998 and 2014, his most popular works were:
- Essential Role of Tumor Necrosis Factor α (TNF-α) in Tumor Promotion as Revealed by TNF-α-deficient Mice (289 citations)
- Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. (229 citations)
- Green tea and cancer chemoprevention. (186 citations)
In his most recent research, the most cited papers focused on:
Hirota Fujiki mainly focuses on Cancer, Internal medicine, Anticarcinogen, Tumor promotion and Cancer prevention.
His work on Breast cancer as part of general Cancer study is frequently connected to Green tea extract, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
As a part of the same scientific study, Hirota Fujiki usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Cytokine.
His work investigates the relationship between Anticarcinogen and topics such as Apoptosis that intersect with problems in Catechin.
His Tumor promotion study integrates concerns from other disciplines, such as Tumor progression, Okadaic acid, Biotechnology and Caffeine.
His study explores the link between Tumor necrosis factor alpha and topics such as Biochemistry that cross with problems in Tamoxifen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
